Page 22 - MemoriaBBN-Eng

SCIENTIFIC PROGRAMMES

ducive environment for designing devices; as many diagnostic or therapeutic objecti-

ves as needed can be established. Problems concerning the measurement of biomedi-
cal variables at any integration level highlight the need of specific instrumentation with

respect to the variables to be measured and the functionality and operating conditions

required.
The development of new biomedical imaging and signal analysis techniques for the

early diagnosis of prevalent pathologies or for molecular studies requires new medical

imaging and signal devices and systems. This need further requires prior develop-
ments for animal models that allow essential experimentation with said technologies.

In addition, in a better and more informed society that seeks higher healthcare quality

and has ever-increasing access to technology, it is logical to think of a research that

aims to introduce more portable and efficient medical devices that that offer greater
degree of autonomy with respect to the clinical specialist and incorporate a certain

degree of intelligence. In summary, the development of “personal assistants”, along
Úwith sensor network technologies for intelligent health environments and lab-on-a-

chip, form the paradigm of care identified today as a point of care. Research in remote

monitoring systems are, among many examples, some challenges of this strategic
line. The implantation of these devices will involve a greater degree of autonomy for

the patients and will translate into lightening the work load of healthcare personnel,

significantly increasing patients’ quality of life.

Additionally, the research results from this line will offer a more thorough and conti-
nuous control of the patients since the evolution of their health condition can be trac-

ked and different variables can be monitored simultaneously.

éIntramural A total of 13 intramural projects are carried out in the Bioengineering Programme in
2012-2013:
projects of the
é
programme

PROGLIO
Optimizing diagnosis, prognosis and therapy response in
human glioma. Preclinical and translational studies.
ú

Coordinating PI: Carles Ars / Participating PIs: J. Blanco, A. Villaverde, á
R. Mangues, S. Penads, S. Schwartz, A. Santos.

Development of new therapies for degenerative retinal
RETINA
diseases.

Coordinating PI: Eduardo Fernndez / Participating PIs: J. Aguiló, M.
Calonge, J. L. Pedraz, P. Botella (external group, CSIC)

Indexes obtained from computational models and multiscale
INDI- multimodal biomedical signals for the diagnosis of cardiac
MSICA
pathologies. 13
20
Coordinating PI: Pablo Laguna / Participating PIs: R. Jané, M. Doblaré, A. T
Frangi, J. Sanz (external group, Polytechnical Univ. of Valencia)
R
PO
Advanced micro-chamber for organotypic cell culture E
MICHOR- L R
MON
monitoring.
óA
Coordinating PI: Bernardo Celda / Participating PIs: J. Aguil, R. Martínez, NU
N
F. Pozo, S. Penads, L. Roa.
A
/
PERSONA
Personalized Decision Support System for Enhanced Control BN
in Healthcare Platforms. B
R-
Coordinating PI: Francisco del Pozo / Participating PIs: A. Leiva, L. Roa.
BE
CI

22